Clinical Trial Update: A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months

View source ↗

Summary

This entry reports the completion of a longitudinal clinical trial evaluating the effects of Copaxone (glatiramer acetate) in relapsing-remitting multiple scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: University at Buffalo | Conditions: Multiple Sclerosis | Status: COMPLETED